Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Mustea

Showing results (31-40 of 172) with videos related to

Pageof 18
Sort By:
Anticancer Research|March 2, 2018
Characterization and Management of Borderline Ovarian Tumors - Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine GreifswaldDominique Koensgen, Martin Weiss, Kathrin Assmann, et al.
Molecular Medicine Reports|July 1, 2016
Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancerPengming Sun, Zhongqing Jiang, Xiaofang Chen, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 17, 2005
Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cellsPengming Sun, Jalid Sehouli, Carsten Denkert, et al.
Anticancer Research|December 12, 2003
Prognostic significance of epithelial cells in the blood of patients with gynaecological malignanciesJalid Sehouli, Dominique Könsgen, Robert Nimpsch, et al.
International Journal of Molecular Sciences|June 2, 2021
Cold Atmospheric Plasma Promotes Regeneration-Associated Cell Functions of Murine Cementoblasts In VitroBenedikt Eggers, Jana Marciniak, James Deschner, et al.
Journal of Cancer Research and Clinical Oncology|April 17, 2023
TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic targetMateja Condic, Eva K Egger, Niklas Klümper, et al.
Anticancer Research|October 3, 2022
Tumor Load Matters - the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian CancerEva Egger, Freya Merker, Damian J Ralser, et al.
Investigational New Drugs|July 12, 2019
Dirty deeds done dirt cheap: sensitization of prostate cancer cells to abiraterone treatment using hydroxylated polychlorinated biphenylsGabriel Daragan, Jenny Hoffmann, Theresa Vasko, et al.
Archives of Gynecology and Obstetrics|April 28, 2015
Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGOMartin Pölcher, Steffen Hauptmann, Christina Fotopoulou, et al.
Archives of Gynecology and Obstetrics|February 20, 2016
The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implicationsIvo Meinhold-Heerlein, Christina Fotopoulou, Philipp Harter, et al.
Pageof 18

Showing results (31-40 of 172) with videos related to

Sort By:
Pageof 18
Anticancer Research|March 2, 2018
Characterization and Management of Borderline Ovarian Tumors - Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine GreifswaldDominique Koensgen, Martin Weiss, Kathrin Assmann, et al.
Molecular Medicine Reports|July 1, 2016
Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancerPengming Sun, Zhongqing Jiang, Xiaofang Chen, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 17, 2005
Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cellsPengming Sun, Jalid Sehouli, Carsten Denkert, et al.
Anticancer Research|December 12, 2003
Prognostic significance of epithelial cells in the blood of patients with gynaecological malignanciesJalid Sehouli, Dominique Könsgen, Robert Nimpsch, et al.
International Journal of Molecular Sciences|June 2, 2021
Cold Atmospheric Plasma Promotes Regeneration-Associated Cell Functions of Murine Cementoblasts In VitroBenedikt Eggers, Jana Marciniak, James Deschner, et al.
Journal of Cancer Research and Clinical Oncology|April 17, 2023
TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic targetMateja Condic, Eva K Egger, Niklas Klümper, et al.
Anticancer Research|October 3, 2022
Tumor Load Matters - the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian CancerEva Egger, Freya Merker, Damian J Ralser, et al.
Investigational New Drugs|July 12, 2019
Dirty deeds done dirt cheap: sensitization of prostate cancer cells to abiraterone treatment using hydroxylated polychlorinated biphenylsGabriel Daragan, Jenny Hoffmann, Theresa Vasko, et al.
Archives of Gynecology and Obstetrics|April 28, 2015
Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGOMartin Pölcher, Steffen Hauptmann, Christina Fotopoulou, et al.
Archives of Gynecology and Obstetrics|February 20, 2016
The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implicationsIvo Meinhold-Heerlein, Christina Fotopoulou, Philipp Harter, et al.
Pageof 18